Development of tandem mass spectrometry-based creatinine measurement using dried blood spot for newborn mass screening

Pediatric Research

Volumn 82, Issue 2, 2017, Pages 237-243

  Nakano, Masaru ^a   Uemura, Osamu ^b   Honda, Masataka ^c   Ito, Tetsuya ^d   Nakajima, Yoko ^d   Saitoh, Shinji ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Japanese Red Cross Toyota College of Nursing   (Japan)

^c TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

APGAR SCORE; ARTICLE; BODY WEIGHT; CHILD; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; DRIED BLOOD SPOT TESTING; FEMALE; GESTATIONAL AGE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SCREENING; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; BLOOD; LIQUID CHROMATOGRAPHY; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY;

CHROMATOGRAPHY, LIQUID; CREATININE; DRIED BLOOD SPOT TESTING; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 85027328378     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2017.56     Document Type: Article

References (33)

1. Ishikura K, Uemura O, Hamasaki Y, et al. Progression to end-stage kidney disease in Japanese children with chronic kidney disease: results of a nationwide prospective cohort study. Nephrol Dial Transplant 2014; 29: 878-4
2. Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106: 100-5
3. Chadha V, Warady BA. Epidemiology of pediatric chronic kidney disease. Adv Chronic Kidney Dis 2005; 12: 343-52
4. Mitsnefes MM, Laskin BL, Dahhou M, Zhang X, Foster BJ. Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010. JAMA 2013; 309: 1921-9
5. Hadtstein C, Schaefer F. Hypertension in children with chronic kidney disease: pathophysiology and management. Pediatr Nephrol 2008; 23: 363-71
6. Wühl E, Schaefer F. Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol 2008; 23: 705-16
7. Ellis D, Vats A, Moritz ML, Reitz S, Grosso MJ, Janosky JE. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria. J Pediatr 2003; 143: 89-97
8. Wühl E, Trivelli A, Picca S, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009; 361: 1639-50
9. Ellis D, Moritz ML, Vats A, Janosky JE. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders. Am J Hypertens 2004; 17: 928-35
10. Soergel M, Verho M, Wühl E, Gellermann J, Teichert L, Schärer K. Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension. Pediatr Nephrol 2000; 15: 113-8
11. White CT, Macpherson CF, Hurley RM, Matsell DG. Antiproteinuric effects of enalapril and losartan: a pilot study. Pediatr Nephrol 2003; 18: 1038-43
12. Simonetti GD, von Vigier RO, Konrad M, Rizzi M, Fossali E, Bianchetti MG. Candesartan cilexetil in children with hypertension or proteinuria: preliminary data. Pediatr Nephrol 2006; 21: 1480-2
13. von Vigier RO, Zberg PM, Teuffel O, Bianchetti MG. Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease. Eur J Pediatr 2000; 159: 590-3
14. Yanagihara T, Hamada R, Ishikura K, et al. Urinary screening and urinary abnormalities in 3-year-old children in Japan. Pediatr Int 2015; 57: 354-8
15. Sekhar DL, Wang L, Hollenbeak CS, Widome MD, Paul IM. A costeffectiveness analysis of screening urine dipsticks in well-child care. Pediatrics 2010; 125: 660-3
16. Uemura O, Honda M, Matsuyama T, et al. Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study. Clin Exp Nephrol 2011; 15: 694-9
17. Uemura O, Nagai T, Ishikura K, et al. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol 2014; 18: 626-33
18. Boer DP, de Rijke YB, Hop WC, Cransberg K, Dorresteijn EM. Reference values for serum creatinine in children younger than 1 year of age. Pediatr Nephrol 2010; 25: 2107-13
19. Bueva A, Guignard JP. Renal function in preterm neonates. Pediatr Res 1994; 36: 572-7
20. van den Anker JN, de Groot R, Broerse HM, et al. Assessment of glomerular filtration rate in preterm infants by serum creatinine: comparison with inulin clearance. Pediatrics 1995; 96: 1156-8
21. Linda L, Ng PD. Validation of Chromatographic Methods. US Food and Drug Administration: Silver Spring, MD, 2014
22. Kanda Y. Investigation of the freely available easy-to-use software EZR for medical statistics. Bone Marrow Transplant 2013; 48: 452-8
23. Pottel H, Vrydags N, Mahieu B, Vandewynckele E, Croes K, Martens F. Establishing age/sex related serum creatinine reference intervals from hospital laboratory data based on different statistical methods. Clin Chim Acta 2008; 396: 49-55
24. Rashed MS. Clinical applications of tandem mass spectrometry: ten years of diagnosis and screening for inherited metabolic diseases. J Chromatogr B Biomed Sci Appl 2001; 758: 27-48
25. den Burger JC, Wilhelm AJ, Chahbouni AC, Vos RM, Sinjewel A, Swart EL. Haematocrit corrected analysis of creatinine in dried blood spots through potassium measurement. Anal Bioanal Chem 2015; 407: 621-7
26. Koop DR, Bleyle LA, Munar M, Cherala G, Al-Uzri A. Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 926: 54-61
27. Jopling J, Henry E, Wiedmeier SE, Christensen RD. Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: data from a multihospital health care system. Pediatrics 2009; 123: e333-7
28. Nagasaki K, Minamitani K, Anzo M, et al. Guidelines for mass screening of congenital hypothyroidism (2014 revision). Clin Pediatr Endocrinol 2015; 24: 107-33
29. Gary LH, Blas C, Donald HC, Sara C. Newborn Screening by Tandem Mass Spectrometry; Approved Guideline. Clinical and Laboratory Standards Institute: Wayne, PA, 2010
30. Schwartz GJ, Feld LG, Langford DJ. A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 1984; 104: 849-54
31. Bariciak E, Yasin A, Harrold J, Walker M, Lepage N, Filler G. Preliminary reference intervals for cystatin C and beta-trace protein in preterm and term neonates. Clin Biochem 2011; 44: 1156-59
32. Lim E, Miyamura J, Chen JJ. Racial/ethnic-specific reference intervals for common laboratory tests: a comparison among Asians, Blacks, Hispanics, and White. Hawaii J Med Public Health 2015; 74: 302-10
33. Tabel Y, Haskologlu ZS, Karakas HM, Yakinci C. Ultrasonographic screening of newborns for congenital anomalies of the kidney and the urinary tracts. Urol J 2010; 7: 161-7